Correlation Between Lantern Pharma and Viking Therapeutics
Can any of the company-specific risk be diversified away by investing in both Lantern Pharma and Viking Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lantern Pharma and Viking Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lantern Pharma and Viking Therapeutics, you can compare the effects of market volatilities on Lantern Pharma and Viking Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lantern Pharma with a short position of Viking Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lantern Pharma and Viking Therapeutics.
Diversification Opportunities for Lantern Pharma and Viking Therapeutics
0.35 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Lantern and Viking is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding Lantern Pharma and Viking Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Viking Therapeutics and Lantern Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lantern Pharma are associated (or correlated) with Viking Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Viking Therapeutics has no effect on the direction of Lantern Pharma i.e., Lantern Pharma and Viking Therapeutics go up and down completely randomly.
Pair Corralation between Lantern Pharma and Viking Therapeutics
Given the investment horizon of 90 days Lantern Pharma is expected to under-perform the Viking Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Lantern Pharma is 1.2 times less risky than Viking Therapeutics. The stock trades about -0.09 of its potential returns per unit of risk. The Viking Therapeutics is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest 7,821 in Viking Therapeutics on September 3, 2024 and sell it today you would lose (2,527) from holding Viking Therapeutics or give up 32.31% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Lantern Pharma vs. Viking Therapeutics
Performance |
| Timeline |
| Lantern Pharma |
| Viking Therapeutics |
Lantern Pharma and Viking Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Lantern Pharma and Viking Therapeutics
The main advantage of trading using opposite Lantern Pharma and Viking Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lantern Pharma position performs unexpectedly, Viking Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Viking Therapeutics will offset losses from the drop in Viking Therapeutics' long position.| Lantern Pharma vs. Tff Pharmaceuticals | Lantern Pharma vs. Generation Bio Co | Lantern Pharma vs. Lyra Therapeutics | Lantern Pharma vs. Immunome |
| Viking Therapeutics vs. DiaMedica Therapeutics | Viking Therapeutics vs. Lyra Therapeutics | Viking Therapeutics vs. Centessa Pharmaceuticals PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |